TY - JOUR
T1 - Mitochondria consume energy and compromise cellular membrane potential by reversing ATP synthetase activity during focal ischemia in rats
AU - Takeda, Yoshimasa
AU - Pérez-Pinzón, Miguel A.
AU - Ginsberg, Myron D.
AU - Sick, Thomas J.
PY - 2004/9
Y1 - 2004/9
N2 - The direction of the chemical reaction of ATP synthetase is reversible. The present study was designed to determine whether mitochondria produce or consume ATP during ischemia. For this purpose, changes in mitochondria membrane potential were measured in vivo at the site of a direct current (DC) electrode using a potentiometric dye, 5,5′,6,6′-tetrachloro-1,1′,3, 3′-tetraethylbenzimidazolylcarbocyanine iodide (JC-1), and a rat model of focal ischemia. Two μL of dye (control group) or dye with oligomycin, an ATP synthetase inhibitor (oligomycin group), was injected into the parietotemporal cortex through the DC electrode. With the initiation of ischemia, a decrease in mitochondrial potential was observed within 20 seconds in the oligomycin group (earlier than the onset of DC deflection, P = 0.02). In contrast, in the control group, mitochondrial potential was maintained at 91 ± 5% of the pre-ischemia level for 118 ± 38 seconds before showing full depolarization simultaneously with DC deflection. During the period of ischemia, the mitochondrial potential was higher in the control group (66 ± 9%) than in the oligomycin group (46 ± 8%, P = 0.0002), whereas DC potential was lower in the control group (-18 ± 3) than in the oligomycin group (-15 ± 2 mV, P = 0.04). These observations suggest that mitochondria consume ATP during ischemia by reversing ATP synthetase activity, which compromises cellular membrane potential by consuming ATP.
AB - The direction of the chemical reaction of ATP synthetase is reversible. The present study was designed to determine whether mitochondria produce or consume ATP during ischemia. For this purpose, changes in mitochondria membrane potential were measured in vivo at the site of a direct current (DC) electrode using a potentiometric dye, 5,5′,6,6′-tetrachloro-1,1′,3, 3′-tetraethylbenzimidazolylcarbocyanine iodide (JC-1), and a rat model of focal ischemia. Two μL of dye (control group) or dye with oligomycin, an ATP synthetase inhibitor (oligomycin group), was injected into the parietotemporal cortex through the DC electrode. With the initiation of ischemia, a decrease in mitochondrial potential was observed within 20 seconds in the oligomycin group (earlier than the onset of DC deflection, P = 0.02). In contrast, in the control group, mitochondrial potential was maintained at 91 ± 5% of the pre-ischemia level for 118 ± 38 seconds before showing full depolarization simultaneously with DC deflection. During the period of ischemia, the mitochondrial potential was higher in the control group (66 ± 9%) than in the oligomycin group (46 ± 8%, P = 0.0002), whereas DC potential was lower in the control group (-18 ± 3) than in the oligomycin group (-15 ± 2 mV, P = 0.04). These observations suggest that mitochondria consume ATP during ischemia by reversing ATP synthetase activity, which compromises cellular membrane potential by consuming ATP.
KW - Brain ischemia
KW - DC potential
KW - Membrane depolarization
KW - Mitochondrial potential
KW - Neuronal damage
KW - Preconditioning
UR - http://www.scopus.com/inward/record.url?scp=4544324815&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=4544324815&partnerID=8YFLogxK
U2 - 10.1097/01.WCB.0000127966.84050.61
DO - 10.1097/01.WCB.0000127966.84050.61
M3 - Article
C2 - 15356419
AN - SCOPUS:4544324815
SN - 0271-678X
VL - 24
SP - 986
EP - 992
JO - Journal of Cerebral Blood Flow and Metabolism
JF - Journal of Cerebral Blood Flow and Metabolism
IS - 9
ER -